Literatur

Potential benefit of probiotic E. coli Nissle in term neonates.

In: Klin. Padiatr. 235 (4), S. 213–220. DOI: 10.1055/a-1970-4340.

Weitere Veröffentlichungen:

Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers.

Weitere Informationen

Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants.

Weitere Informationen

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis. A randomised trial.

Weitere Informationen

Olbertz, Dirk; Proquitté, Hans; Patzer, Ludwig; Erler, Thomas; Mikolajczak, Alexsandra; Sadowska-Krawczenko, Iwona et al. (2023): Potential benefit of probiotic E. coli Nissle in term neonates.